The neuropeptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro

Regulatory Peptides

Volumn 110, Issue 1, 2002, Pages 65-73

  Kähler, Christian M ^a   Kaufmann, Gerhard ^a   Kähler, Stefan T ^b   Wiedermann, Christian J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adhesion; Endothelial cells; Mono Mac 6; Monocyte; Neuropeptide; Secretoneurin; U937

Indexed keywords

INTERLEUKIN 1; LIPOPOLYSACCHARIDE; SECRETONEURIN; TUMOR NECROSIS FACTOR ALPHA; NEUROPEPTIDE; SECRETOGRANIN II;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CELL ADHESION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; KINETICS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANTIBODY SPECIFICITY; CELL CULTURE; CELL STRAIN U937; COMPARATIVE STUDY; CYTOLOGY; FLUOROMETRY; IMMUNOLOGY; METHODOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; THORACIC AORTA; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODY SPECIFICITY; AORTA, THORACIC; CELL ADHESION; ENDOTHELIUM, VASCULAR; FEMALE; FLUOROMETRY; HUMANS; INTERLEUKIN-1; KINETICS; LIPOPOLYSACCHARIDES; MONOCYTES; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SECRETOGRANIN II; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; UMBILICAL VEINS;

EID: 0037207061     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00161-1     Document Type: Article

References (44)

1. Folkman J., Brem H. Angiogenesis and inflammation. Inflammation: basic principles and clinical correlates. 1992;821-839 Raven Press, New York.
2. Cybulsky M.I., Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during artherogenesis. Science. 251:1991;788-791.
3. 4-integrin supports leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo. J. Exp. Med. 183:1996;1995-2006.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-808.
5. Kähler C.M., Kaufmann G., Hogue-Angeletti R., Fischer-Colbrie R., Dunzendorfer S., Reinisch N.et al. A soluble gradient of the novel neuropeptide secretoneurin promotes transendothelial migration of monocytes in vitro. Eur. J. Pharmacol. 365:1999;65-75.
6. Hirata Y., Takagi Y., Takata S., Fukuda Y., Yoshimi H., Fujita T. Calcitonin-gene related peptide receptor in cultured vascular smooth muscle and endothelial cells. Biochem. Biophys. Res. Commun. 151:1988;1113-1121.
7. Berthiaume N., Claing A., Regoli D., Warner T.D., D'Orleans-Juste P. Characterization of receptors for kinins and neurokinins in the arterial and venous mesenteric vasculatures of the guinea-pig. Br. J. Pharmacol. 115:1995;1319-1325.
8. Sanabria P., Silva W.I. Specific 125I neuropeptide Y binding to intact cultured bovine adrenal medulla capillary endothelial cells. Microcirculation. 1:1994;267-273.
9. Iwamoto I., Nadel J.A. Tachykinin receptor subtype that mediates the increase in vascular permeability in guinea pig skin. Life Sci. 44:1989;1089-1095.
10. Winkler H., Fischer-Colbrie R. The chromogranins A, B and C: the first 25 years and future perspectives. Neuroscience. 49:1992;497-528.
11. Fischer-Colbrie R., Hagn C., Kirkpatrick L., Winkler H. Chromogranin C: a third component of the acidic proteins in chromaffin granules. J. Neurochem. 47:1986;318-321.
12. Rosa P., Hille A., Lee R.W.H., Zanini A., De Camilli P., Huttner W.B. Secretogranin I and II: two tyrosine sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway. J. Cell. Biol. 101:1985;1999-2011.
13. Fischer-Colbrie R., Hagn C., Schober M. Chromogranins A, B and C: widespread constituents of secretory vesicles. Ann. N. Y. Acad. Sci. 493:1987;120-134.
14. Huttner W.B., Gerdes H.H., Rosa P. Chromogranins/secretogranins: widespread constituents of the secretory granule matrix in endocrine cells and neurons. Gratzl M., Langley K. Markers for neuron and endocrine cells. 1991;93-131 VCH, Weinheim, Germany.
15. Vaudry H., Conlon J.M. Identification of a peptide arising from the specific post-translation processing from secretogranin II. FEBS Lett. 284:1991;31-33.
16. Kirchmair R., Hogue-Angeletti R., Gutierrez J., Fischer-Colbrie R., Winkler H. Secretoneurin-a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience. 53:1993;359-365.
17. Wiedermann C.J. Secretoneurin: a functional neuropeptide in health and disease. Peptides. 21:2000;1289-1298.
18. Leitner B., Kirchmair R., Fischer-Colbrie R., Winkler H. Secretoneurin levels in human serum. Neuropeptides. 26:1994;26. [suppl.].
19. Marksteiner J., Kirchmair R., Mahata S.K., Mahata M., Donnerer J.et al. Distribution of secretoneurin, a peptide derived from secretogranin II, in rat brain. An immunocytochemical and radioimmunological study. Neuroscience. 54:1993;923-944.
20. Saria A., Troger J., Kirchmair R., Fischer-Colbrie R., Hogue-Angeletti R., Winkler H. Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C). Neuroscience. 54:1994;1-4.
21. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience. 15:1985;1159-1181.
22. Kirchmair R., Marksteiner J., Troger J., Mahata S.K., Mahata M., Donnerer J.et al. Human and rat primary C-fibre afferents store and release secretoneurin, a novel neuropeptide. Eur. J. Neurosci. 6:1994;861-868.
23. Dunzendorfer S., Schratzberger P., Reinisch N., Kähler C.M., Wiedermann C.J. Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils. Blood. 91:1998;1527-1532.
24. Kähler C.M., Schratzberger P., Wiedermann C.J. Response of vascular smooth muscle cells to the neuropeptide secretoneurin. A functional role for migration and proliferation in vitro. Arterioscler. Thromb. Vasc. Biol. 7:1997;2029-2035.
25. Kähler C.M., Kirchmair R., Kaufmann G., Kähler S.T., Reinisch N., Fischer-Colbrie R.et al. Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro. Arterioscler. Thromb. Vasc. Biol. 17:1997;932-939.
26. Kähler C.M., Bellmann R., Reinisch N., Schratzberger P., Gruber B., Wiedermann C.J. Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin. Eur. J. Pharmacol. 304:1996;135-139.
27. Reinisch N., Kirchmair R., Kähler C.M., Hogue-Angeletti R., Fischer-Colbrie R., Winkler H.et al. Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett. 334:1993;41-44.
28. Kähler C.M., Kaufmann G., Hogue-Angeletti R., Fischer-Colbrie R., Dunzendorfer S., Reinisch N.et al. A soluble gradient of the neuropeptide secretoneurin promotes the transendothelial migration of monocytes in vitro. Eur. J. Pharmacol. 365:1999;65-75.
29. Kong C., Gill B.M., Rahimpour R., Xu L., Feldman R.D., Xiao Q.et al. Secretoneurin and chemoattractant receptor interactions. J. Neuroimmunol. 88:1998;91-98.
30. 125I-secretoneurin-analogue to a human monocytic cell line. J. Neuroimmunol. 86:1998;87-91.
31. Schratzberger P., Wöll E., Reinisch N., Kähler C.M., Wiedermann C.J. Secretoneurin-induced in vitro chemotaxis of human monocytes is inhibited by pertussis toxin and an inhibitor of protein kinase C. Neurosci. Lett. 214:1996;208-210.
32. Storch M.K., Fischer-Colbrie R., Smith T., Rinner W.A., Hickey W.F., Cuzner M.L.et al. Co-localization of secretoneurin immunoreactivity and macrophage infiltration in the lesions of experimental autoimmune encephalomyelitis. Neuroscience. 71:1996;885-893.
33. Chuluyan H.E., Issekutz A.C. VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes. J. Clin. Invest. 92:1993;2768-2777.
34. Ziegelstein R.C., Corda S., Pili R., Passaniti A., Lefer D., Zweier J.L.et al. Initial contact and subsequent adhesion of human neutrophils or monocytes to human aortic endothelial cells releases an endothelial intracellular calcium store. Circulation. 90:1994;1899-1907.
35. Erl W., Weber C., Wardemann C., Weber P.C. Adhesion properties of Mono Mac 6, a monocytic cell line with characteristics of mature human monocytes. Atherosclerosis. 113:1995;99-107.
36. Emeis J.J., Edgell C.J. Fibrinolytic properties of a human endothelial hybrid cell line (Ea.hy 926). Blood. 71:1988;1669-1675.
37. Van Oost B.A., Edgell C.J., Hay C.W., MacGillivray R.T. Isolation of a human von Willebrand factor cDNA from the hybrid endothelial cell line EA.hy926. Biochem. Cell. Biol. 64:1986;699-705.
38. Suggs J.E., Madden M.C., Friedman M., Edgell C.J. Prostacyclin expression by a continuous human cell line derived from vascular endothelium. Blood. 68:1986;825-829.
39. Bussolino F., Biffignandi P., Arese P. Platelet-activating factor - a powerful lipid autacoid possibly involved in microangiopathy. Acta Haematol. 75:1986;129-140.
40. Saijonmaa O., Nyman T., Hohenthal U., Fyhrquist F. Endothelin-1 is expressed and released by a human endothelial hybrid cell line (EA.hy 926). Biochem. Biophys. Res. Commun. 81:1986;529-536.
41. Brown K.A., Vora A., Biggerstaff J., Edgell C.J., Oikle S., Mazure G.et al. Application of an immortalized human endothelial cell line to the leucocyte: endothelial adherence assay. J. Immunol. Methods. 163:1993;13-22.
42. Gruber B., Schratzberger P., Kähler C.M., Dunzendorfer S., Bellmann R., Reinisch N.et al. Staurosporine-dependent activation of human endothelial cell monolayers for neutrophil adherence by secretoneurin. Peptides. 18:1997;1445-1447.
43. De Clerck L.S., Bridts C.H., Mertens A.M., Moens M.M., Stevens W.J. Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function. J. Immunol. Methods. 72:1994;115-124.
44. Takahashi M., Ikeda U., Masuyama J., Kitagawa S., Kasahara T., Saito M.et al. Involvement of adhesion molecules in human monocyte adhesion to and transmigration through endothelial cells in vitro. Atherosclerosis. 108:1994;73-81.